Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

NFX

Nuformix (NFX)

Nuformix Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:NFX
FechaHoraFuenteTítuloSímboloCompañía
19/03/202409:39RNS Regulatory NewsNuformix PLC Result of AGMLSE:NFXNuformix Plc
01/03/202404:31Alliance NewsAlliance NewsIN BRIEF: Nuformix announces subscription to raise GBP150,000LSE:NFXNuformix Plc
01/03/202401:00RNS Regulatory NewsNuformix PLC Subscription to raise £150,000LSE:NFXNuformix Plc
15/01/202405:30UK RegulatoryNuformix PLC Posting of Annual Report and Notice of AGMLSE:NFXNuformix Plc
03/01/202404:16Alliance NewsAlliance NewsIN BRIEF: Nuformix narrows annual loss as develops drug assetsLSE:NFXNuformix Plc
03/01/202401:00UK RegulatoryNuformix PLC Results for the period ended 30 September 2023LSE:NFXNuformix Plc
18/12/202301:00UK RegulatoryNuformix PLC NXP001 UpdateLSE:NFXNuformix Plc
23/10/202306:38Alliance NewsAlliance NewsNuformix gets patent in Japan for pulmonary fibrosis treatment NXP002LSE:NFXNuformix Plc
23/10/202301:04UK RegulatoryNuformix PLC Notice of Allowance of NXP002 Patent in JapanLSE:NFXNuformix Plc
18/09/202304:20Alliance NewsAlliance NewsIN BRIEF: Nuformix to receive milestone payments from Oxilio pactLSE:NFXNuformix Plc
24/08/202307:22UK RegulatoryNuformix PLC Result of Annual General MeetingLSE:NFXNuformix Plc
31/07/202308:00UK RegulatoryNuformix PLC Notice of AGMLSE:NFXNuformix Plc
26/07/202308:55UK RegulatoryNuformix PLC Holding(s) in CompanyLSE:NFXNuformix Plc
02/06/202301:00RNS Non-RegulatoryNuformix PLC Investor Online Q&ALSE:NFXNuformix Plc
25/05/202301:00UK RegulatoryNuformix PLC Change of AuditorLSE:NFXNuformix Plc
22/05/202306:45Alliance NewsAlliance NewsNuformix loss narrows; near-term goal to focus on NXP002 assetLSE:NFXNuformix Plc
22/05/202301:00UK RegulatoryNuformix PLC Unaudited Interim ReportLSE:NFXNuformix Plc
18/05/202308:31Alliance NewsAlliance NewsTRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effectLSE:NFXNuformix Plc
18/05/202301:00UK RegulatoryNuformix PLC NXP002 Inflammation and Duration of Action UpdateLSE:NFXNuformix Plc
17/04/202306:14Alliance NewsAlliance NewsNuformix raises GBP70,000 to fund NXP002 programmeLSE:NFXNuformix Plc
17/04/202301:00UK RegulatoryNuformix PLC Subscription to raise GBP70,000 & issue of WarrantsLSE:NFXNuformix Plc
27/03/202312:42Alliance NewsAlliance NewsTRADING UPDATES: Sabien works with Empiric; Coro sells in ItalyLSE:NFXNuformix Plc
27/03/202301:00UK RegulatoryNuformix PLC NXP002 UpdateLSE:NFXNuformix Plc
13/03/202302:00UK RegulatoryNuformix PLC Change of Accounting Reference DateLSE:NFXNuformix Plc
15/02/202306:12Alliance NewsAlliance NewsNuformix progresses NXP002 trial after acquiring human tissueLSE:NFXNuformix Plc
20/12/202201:00UK RegulatoryNuformix PLC NXP004 UpdateLSE:NFXNuformix Plc
13/12/202208:54Alliance NewsAlliance NewsNuformix interim loss virtually flat as continues work on drugsLSE:NFXNuformix Plc
13/12/202201:00UK RegulatoryNuformix PLC Half-year ReportLSE:NFXNuformix Plc
05/12/202201:00UK RegulatoryNuformix PLC Resignation of AuditorLSE:NFXNuformix Plc
04/11/202202:00RNS Non-RegulatoryNuformix PLC Investor WebinarLSE:NFXNuformix Plc
 Showing the most relevant articles for your search:LSE:NFX